486 related items for PubMed ID: 18266402
1. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A, Jacques L, Frith L.
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[Abstract] [Full Text] [Related]
2. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W, Goryachkina L, Jacques L, Frith L.
Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
[Abstract] [Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
4. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[Abstract] [Full Text] [Related]
5. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
6. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
J Asthma; 2007 Dec; 44(6):437-41. PubMed ID: 17654129
[Abstract] [Full Text] [Related]
7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[Abstract] [Full Text] [Related]
8. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
10. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC, Lindemann L, Braun R, Steinkamp G.
Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658
[Abstract] [Full Text] [Related]
11. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
Can Respir J; 1999 Jan 24; 6(1):45-51. PubMed ID: 10202220
[Abstract] [Full Text] [Related]
12. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED, Silins V, Bogolubov M.
Respir Med; 2001 Feb 24; 95(2):136-46. PubMed ID: 11217910
[Abstract] [Full Text] [Related]
13. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov 24; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
14. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, Bateman ED, International Study Group.
Respir Med; 2003 Mar 24; 97(3):234-41. PubMed ID: 12645830
[Abstract] [Full Text] [Related]
15. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K.
Ann Allergy Asthma Immunol; 1999 Apr 24; 82(4):383-9. PubMed ID: 10227337
[Abstract] [Full Text] [Related]
16. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
Chang Gung Med J; 2011 Apr 24; 34(4):382-94. PubMed ID: 21880193
[Abstract] [Full Text] [Related]
17. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar 24; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
18. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
J Allergy Clin Immunol; 2000 Jun 24; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[Abstract] [Full Text] [Related]
19. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R.
Respir Med; 2006 Jul 24; 100(7):1152-62. PubMed ID: 16675212
[Abstract] [Full Text] [Related]
20. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep 24; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
